Rodrigo Saar da Costa

4PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyMetabolic medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 05, 2026
Real-World Effectiveness, Safety, and Adverse Event Kinetics of Pembrolizumab in Advanced Melanoma within the Brazilian Public Health System.

Hildeneide Rocha Lima, Mahanna Vanzeler Vaz, Rebeka Caribé Badin

|Aug 13, 2025
Time-Driven Activity-Based Costing (TDABC) applied in a chemotherapy department of a public reference oncology hospital.

Amanda Oliveira Serra-Campos, Camila Campos Valério, Liliane Rosa Alves Manaças

|Oct 25, 2023
Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.

Débora Silva Gonçalves, Arn Migowski, Susanne Crocamo Ventilari da Costa

|Aug 29, 2019
[Cost-effectiveness between pazopanib and sunitinib for metastatic renal cancer from the perspective of the Brazilian Unified National Health System].

Isandra Oliveira Meirelles, Dulce Helena Nunes Couto, Rodrigo Saar da Costa

Pageof 1

Frequent Collaborators

2 joint publications

Liliane Rosa Alves Manaças

1 joint publications

Isandra Oliveira Meirelles

1 joint publications

Dulce Helena Nunes Couto

1 joint publications

Débora Silva Gonçalves